Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1964
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1978 2
1979 5
1980 2
1981 2
1982 3
1983 5
1984 5
1985 6
1986 4
1987 4
1988 3
1989 2
1990 2
1991 3
1992 2
1993 1
1994 1
1996 1
1998 3
1999 3
2001 1
2002 1
2003 3
2004 2
2005 1
2006 2
2007 4
2008 1
2010 1
2011 2
2012 1
2013 3
2014 3
2016 1
2017 1
2018 1
2019 1
2020 1
2021 1
2022 1
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Apheresis: What Should a Clinician Know?
Parhofer KG. Parhofer KG. Curr Atheroscler Rep. 2023 Mar;25(3):77-83. doi: 10.1007/s11883-023-01081-7. Epub 2023 Jan 26. Curr Atheroscler Rep. 2023. PMID: 36701088 Free PMC article. Review.
[Primary hyperchylomicronemia].
Yamashita S. Yamashita S. Nihon Rinsho. 2013 Sep;71(9):1578-83. Nihon Rinsho. 2013. PMID: 24205717 Review. Japanese.
This entity includes familial lipoprotein lipase (LPL) deficiency, familial apolipoprotein C-II deficiency, primary type V hyperlipoproteinemia, and idiopathic hyperchylomicronemia. Idiopathic hyperchylomicronemia is caused by an LPL inhibitor or autoantibody agains …
This entity includes familial lipoprotein lipase (LPL) deficiency, familial apolipoprotein C-II deficiency, primary type V hyperli
Chylomicronemia syndrome.
Chait A, Brunzell JD. Chait A, et al. Adv Intern Med. 1992;37:249-73. Adv Intern Med. 1992. PMID: 1557997 Review.
[Acute hypertrygliceridemic pancreatitis].
Senosiain Lalastra C, Tavío Hernández E, Moreira Vicente V, Maroto Castellanos M, García Sánchez MC, Aicart Ramos M, Téllez Vivajos L, Cuño Roldán JL. Senosiain Lalastra C, et al. Gastroenterol Hepatol. 2013 Apr;36(4):274-9. doi: 10.1016/j.gastrohep.2012.11.006. Epub 2013 Mar 20. Gastroenterol Hepatol. 2013. PMID: 23522394 Review. Spanish.
Current Role of Lipoprotein Apheresis.
Thompson G, Parhofer KG. Thompson G, et al. Curr Atheroscler Rep. 2019 May 1;21(7):26. doi: 10.1007/s11883-019-0787-5. Curr Atheroscler Rep. 2019. PMID: 31041550 Free PMC article. Review.
Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA).
Tarugi P, Bertolini S, Calandra S, Arca M, Angelico F, Casula M, Cefalù AB, D'Erasmo L, Fortunato G, Perrone-Filardi P, Rubba P, Suppressa P, Averna M, Catapano AL. Tarugi P, et al. Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):1819-1836. doi: 10.1016/j.numecd.2024.05.002. Epub 2024 May 7. Nutr Metab Cardiovasc Dis. 2024. PMID: 38871496 Review.
DATA SYNTHESIS: Our guidelines include: i) an overview of the genetic complexity of FH and the role of candidate genes involved in LDL metabolism; ii) the prevalence of FH in the population; iii) the clinical criteria adopted for the diagnosis of FH; iv) the screening for …
DATA SYNTHESIS: Our guidelines include: i) an overview of the genetic complexity of FH and the role of candidate genes involved in LDL metab …
Risks for hyperlipidemia.
Nestruck AC, Davignon J. Nestruck AC, et al. Cardiol Clin. 1986 Feb;4(1):47-56. Cardiol Clin. 1986. PMID: 2871933 Review.
Hyperlipidemia is defined by elevated levels of the plasma levels; the risk for atherosclerosis is associated with the classification types IIa, IIb, III, and possibly IV, a classification system based on phenotypic manifestations of increased lipoprotein fractions. ...Reg …
Hyperlipidemia is defined by elevated levels of the plasma levels; the risk for atherosclerosis is associated with the classification types …
Postprandial Hyperlipidemia and Remnant Lipoproteins.
Masuda D, Yamashita S. Masuda D, et al. J Atheroscler Thromb. 2017 Feb 1;24(2):95-109. doi: 10.5551/jat.RV16003. Epub 2016 Nov 8. J Atheroscler Thromb. 2017. PMID: 27829582 Free PMC article. Review.
Fasting apoB-48 levels correlate with the morbidity of postprandial hypertriglyceridemia, obesity, type III hyperlipoproteinemia, the metabolic syndrome, hypothyroidism, chronic kidney disease, and IGT. ...Diet interventions, such as dietary fibers, polyphenols, med …
Fasting apoB-48 levels correlate with the morbidity of postprandial hypertriglyceridemia, obesity, type III hyperlipoproteinemia
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.
Mahley RW, Huang Y, Rall SC Jr. Mahley RW, et al. J Lipid Res. 1999 Nov;40(11):1933-49. J Lipid Res. 1999. PMID: 10552997 Free article. Review.
Type III hyperlipoproteinemia (HLP) is a genetic disorder characterized by accumulation of remnant lipoproteins in the plasma and development of premature atherosclerosis. ...PARADOX III: ApoE deficiency is associated with hypercholesterolemia, whereas the type
Type III hyperlipoproteinemia (HLP) is a genetic disorder characterized by accumulation of remnant lipoproteins in the plasma
94 results